David M. Polen
Polen Capital Management
Polen Capital Management Bio-Techne Corp stake
total: 588
Polen Capital Management TECH trades
- Total transactions:
- 7
- New positions:
- 1
- Sold out:
- 1
- Added:
- 2
- Reduced:
- 3
- Held since:
- 2023 Q4
- Held for:
- 6 quarters
- Latest activity:
- 2025 Q2
According to 2026 Q2 report, Polen Capital Management doesn't hold any Bio-Techne Corp (TECH) shares. To date, the estimated cost basis is nearly $68.01 for "buy" trades and estimated average "sell" price is $63.12. Polen Capital Management first purchased TECH in 2023 Q4, initially acquiring 22,383 shares. Since the initial investment in Bio-Techne Corp (TECH), Polen Capital Management has made 6 more transactions.
When did Polen Capital Management sell Bio-Techne Corp (TECH)?
Polen Capital Management sold off the entire Bio-Techne Corp (TECH) position in 2025 Q2.
When did Polen Capital Management buy Bio-Techne Corp (TECH)?
Polen Capital Management first invested in Bio-Techne Corp (TECH) in 2023 Q4 at the reported quarter-end price of $77.16 per share.
What's the cost basis of Polen Capital Management's TECH stake?
The estimated cost basis for Bio-Techne Corp (TECH) stake is around $68.01 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $68.01
- Weighted AVG sell price:
- $63.12
Polen Capital Management's historical trades in Bio-Techne Corp
7 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2025 Q2
|
0.00%
|
0
|
$58.63
|
|
-100% (-46,314)
|
-0.01%
|
|
2025 Q1
|
0.01%
|
46,314
|
$58.63
|
$2,715,415
|
+123.09% (+25,554)
|
+0%
|
|
2024 Q4
|
0.00%
|
20,760
|
$72.03
|
$1,495,343
|
-24.35% (-6,683)
|
-0%
|
|
2024 Q3
|
0.01%
|
27,443
|
$79.93
|
$2,193,519
|
-22.60% (-8,014)
|
-0%
|
|
2024 Q2
|
0.01%
|
35,457
|
$71.65
|
$2,540,494
|
-4.23% (-1,567)
|
-0%
|
|
2024 Q1
|
0.01%
|
37,024
|
$70.39
|
$2,606,119
|
+65.41% (+14,641)
|
+0%
|
|
2023 Q4
|
0.00%
|
22,383
|
$77.16
|
$1,727,072
|
new
|
+0%
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.